N-[(4-Bromophenyl)methyl]-4-chloro-N-[(3R)-hexahydro-2-oxo-1H-azepin-3-yl]benzenesulfonamide (ELN318463) is a selective γ-secretase inhibitor targeting amyloid precursor protein (APP) processing; it exhibits differential inhibitory activity against γ-secretase complexes containing presenilin-1 (PS1) and presenilin-2 (PS2), with EC50 values of 12 nM and 656 nM, respectively, demonstrating approximately 51-fold selectivity for PS1 over PS2.